Join
Live feed
·
INSIDERFilingvia Quantisnow
CRISPR Therapeutics AG logo

General Counsel and Secretary Kasinger James R. converted options into 7,750 shares and sold $169,242 worth of shares (3,966 units at $42.67), increasing direct ownership by 5% to 78,664 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRSP (CRISPR Therapeutics AG) and more on Quantisnow.